Optinose Announces Departure of Chief Financial Officer
Michele Janis Appointed Acting Chief Financial Officer Anthony Krick Appointed Vice President & Chief Accounting Officer Optinose a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, announced that Keith A. Goldan, Chief Financial Officer, will leave Optinose to accept a CFO opportunity at......